Article info
Basic and translational research
Synergistic benefit in inflammatory arthritis by targeting IκB kinase ϵ and interferon β
- M Corr, Division of Rheumatology, Allergy and Immunology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093–0663, USA; mcorr{at}ucsd.edu
Citation
Synergistic benefit in inflammatory arthritis by targeting IκB kinase ϵ and interferon β
Publication history
- Accepted July 9, 2008
- First published July 24, 2008.
Online issue publication
January 12, 2009
Article Versions
- Previous version (24 July 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism